Kazia Therapeutics (KZIA) EBITDA (2009 - 2017)
Kazia Therapeutics (KZIA) posted EBITDA of -$8.2 million for Q2 2017, up 9.28% on a QoQ basis from -$9.0 million in Q4 2016, and up 10.04% year-over-year from -$7.4 million in Q2 2016.
Kazia Therapeutics (KZIA) EBITDA (2009 - 2017) Analysis & Trends
Kazia Therapeutics' EBITDA history runs 9 years deep, the most recent figure standing at -$8.2 million for Q2 2017.
- Quarterly EBITDA rose 10.04% year-over-year to -$8.2 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was -$31.5 million (down 45.36% YoY) and the FY2025 annual result came in at -$14.4 million, up 18.56% from the prior year.
- EBITDA was -$8.2 million for Q2 2017 at Kazia Therapeutics, up from -$9.0 million in the prior quarter.
- Across five years, EBITDA topped out at -$860683.4 in Q4 2013 and bottomed at -$9.1 million in Q2 2016.
- A 5-year average of -$6.5 million and a median of -$7.3 million in 2014 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2013 — EBITDA soared 43.65% — and 2014, when it tumbled 652.26%.
- Kazia Therapeutics' EBITDA stood at -$860683.4 in 2013, then tumbled by 652.26% to -$6.5 million in 2014, then increased by 18.79% to -$5.3 million in 2015, then tumbled by 71.16% to -$9.0 million in 2016, then rose by 9.28% to -$8.2 million in 2017.
- Business Quant data shows KZIA's EBITDA at -$8.2 million in Q2 2017, -$9.0 million in Q4 2016, and -$9.1 million in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Kazia Therapeutics | 19.25 Bn | 19.25 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -8.16 Mn |
| Dec 31, 2016 | -9.00 Mn |
| Jun 30, 2016 | -9.08 Mn |
| Dec 31, 2015 | -5.26 Mn |
| Dec 31, 2014 | -6.47 Mn |
| Dec 31, 2013 | -860,683.36 |
| Dec 31, 2012 | -1.53 Mn |
| Oct 8, 2012 | -11.38 Mn |
| Dec 31, 2011 | 15.24 Mn |
| Dec 31, 2010 | -5.15 Mn |
| Dec 31, 2009 | -4.78 Mn |